BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16954517)

  • 21. The significance of granzyme B expression in patients with angiocentric lymphoma of the head and neck.
    Kim GE; Yang WI; Lee S; Kim YB; Suh CO; Yoon JH; Oh YT; Chung HC; Kim BS
    Cancer; 2001 Jun; 91(12):2343-52. PubMed ID: 11413524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
    Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
    J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
    Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
    J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
    Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
    J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: immunophenotypic and molecular studies.
    Chan WC
    Semin Hematol; 1999 Jul; 36(3):242-52. PubMed ID: 10462324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
    Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts.
    Atayar C; Poppema S; Visser L; van den Berg A
    J Pathol; 2006 Feb; 208(3):423-30. PubMed ID: 16353293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of Hodgkin lymphoma with Epstein-Barr virus in Hungary].
    Keresztes K; Bessenyei B; Szöllosi Z; Beck Z; Miltényi Z; Nemes Z; Oláh E; Illés A
    Orv Hetil; 2005 Jul; 146(30):1575-82. PubMed ID: 16136734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
    Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases.
    Loo EY; Medeiros LJ; Aladily TN; Hoehn D; Kanagal-Shamanna R; Young KH; Lin P; Bueso-Ramos CE; Manning JT; Patel K; Thomazy V; Brynes RK; Goswami M; Fayad LE; Miranda RN
    Am J Surg Pathol; 2013 Aug; 37(8):1290-7. PubMed ID: 23774171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of imprint cytology in the assessment of Hodgkin's disease in Japan.
    Funamoto Y; Nagai M; Haba R; Ishikawa M; Kishida F; Kohno K; Matsunaga T; Kushida Y; Kobayashi S
    Diagn Cytopathol; 2005 Jul; 33(1):20-5. PubMed ID: 15945083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
    Claviez A; Tiemann M; Lüders H; Krams M; Parwaresch R; Schellong G; Dörffel W
    J Clin Oncol; 2005 Jun; 23(18):4048-56. PubMed ID: 15961758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
    Karube K; Niino D; Kimura Y; Ohshima K
    Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
    Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
    Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin's reed-sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells.
    Tanijiri T; Shimizu T; Uehira K; Yokoi T; Amuro H; Sugimoto H; Torii Y; Tajima K; Ito T; Amakawa R; Fukuhara S
    J Leukoc Biol; 2007 Sep; 82(3):576-84. PubMed ID: 17545218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease.
    Portlock CS; Donnelly GB; Qin J; Straus D; Yahalom J; Zelenetz A; Noy A; O'Connor O; Horwitz S; Moskowitz C; Filippa DA
    Br J Haematol; 2004 Jun; 125(6):701-8. PubMed ID: 15180859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
    Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
    Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma.
    Hasselblom S; Sigurdadottir M; Hansson U; Nilsson-Ehle H; Ridell B; Andersson PO
    Br J Haematol; 2007 May; 137(4):364-73. PubMed ID: 17456059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.